Page last updated: 2024-08-26

norcantharidin and Disease Exacerbation

norcantharidin has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, W; Dai, J; Du, J; Gong, K; Guo, J; Li, X; Wu, Y; Xi, S; Yang, L	1

Other Studies

1 other study(ies) available for norcantharidin and Disease Exacerbation

Article	Year
Repression of YAP by NCTD disrupts NSCLC progression. Oncotarget, 2017, Jan-10, Volume: 8, Issue:2 Topics: A549 Cells; Adaptor Proteins, Signal Transducing; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Phosphoproteins; Signal Transduction; Transcription Factors; YAP-Signaling Proteins	2017

Article

Year

Repression of YAP by NCTD disrupts NSCLC progression.

Oncotarget, 2017, Jan-10, Volume: 8, Issue:2

Topics: A549 Cells; Adaptor Proteins, Signal Transducing; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Disease Progression; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Phosphoproteins; Signal Transduction; Transcription Factors; YAP-Signaling Proteins

2017